Topoisomerase II as a Novel Antiviral Target against Panarenaviral Diseases

Although many arenaviruses cause severe diseases with high fatality rates each year, treatment options are limited to off-label use of ribavirin, and a Food and Drug Administration (FDA)-approved vaccine is not available. To identify novel therapeutic candidates against arenaviral diseases, an RNA p...

Descripción completa

Detalles Bibliográficos
Autores principales: Afowowe, Tosin Oladipo, Sakurai, Yasuteru, Urata, Shuzo, Zadeh, Vahid Rajabali, Yasuda, Jiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866940/
https://www.ncbi.nlm.nih.gov/pubmed/36680145
http://dx.doi.org/10.3390/v15010105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866940/
https://www.ncbi.nlm.nih.gov/pubmed/36680145
http://dx.doi.org/10.3390/v15010105

Ejemplares similares